AKZO NOBEL SPONS.ADRS 1/3 (AKUP) — Capital Reinvestment Ratio
AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has a Capital Reinvestment Ratio of 0.22x as of December 2025, meaning it reinvests 0% of its operating cash flow (€462.00 Million) in capital expenditures (€100.00 Million). See AKZO NOBEL SPONS.ADRS 1/3 (AKUP) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AKZO NOBEL SPONS.ADRS 1/3 Capital Reinvestment Ratio (2022–2025)
This chart tracks AKZO NOBEL SPONS.ADRS 1/3's Capital Reinvestment Ratio across 4 annual periods. Check AKUP cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
Year-by-year Capital Reinvestment Ratio for AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025. For live market cap and broader valuation context, see AKZO NOBEL SPONS.ADRS 1/3 (AKUP) total market value.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | €915.00 Million | €309.00 Million | ▼ -25.7% |
| 2024 | 0.45x | €673.00 Million | €306.00 Million | ▲ +79.0% |
| 2023 | 0.25x | €1.13 Billion | €286.00 Million | ▼ -77.1% |
| 2022 | 1.11x | €263.00 Million | €292.00 Million | — |